ZHENGYE BIOTECHNOLOGY-A
ZYBTNASDAQ🏆 #3824 by market capUS Equity
$283.31▲ $18.73 (+6.61%)
Simulated price1h—
24h▲ 6.6%
7d—
14d—
30d—
1y—
🏦Market Cap
$6M
Small Cap
📈Revenue Growth (YoY)
-4.2%
Declining
📊Gross Margin
24.2%
Moderate
💵FCF Margin
8.6%
Moderate
⚖️P/S Ratio
2.1x
Cheap
Otter Score
64
Fair
No chart data available for ZYBT.
Trading Snapshot
- Day Range
- $278.92 – $287.26
- 52-Week Range
- —
- Volume
- $3.14B
- Avg Volume
- $2.43B
- Shares Outstanding
- 29.7M
- Next Earnings
- Sep 21, 2026
Fundamentals Snapshot
- Annual Revenue
- $3M
- Last Q Revenue
- $640,823
- P/E Ratio
- —
- P/S Ratio
- 2.1x
- EPS (TTM)
- —
- Dividend Yield
- 0.00%
Why Investors Own ZYBT
- ✓High-growth profile — revenue up +26.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 59% gross margin and 12% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$3M▲ +27.8% YoY
Gross Margin (TTM)
58.8%▲ +4.5% YoY
Operating Income (TTM)
$766,922▲ +27.8% YoY
Free Cash Flow (TTM)
$333,079▲ +27.8% YoY
About ZHENGYE BIOTECHNOLOGY-A
A company profile for ZHENGYE BIOTECHNOLOGY-A isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
64/100
Analyst Price Target
ⓘAverage Target
$358.65
▲ +26.6% Upside
High Target$441.10
Low Target$310.98
Based on 33 analysts
Latest News & Updates
🚀
Bloomberg·2h ago
ZHENGYE BIOTECHNOLOGY-A tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Bloomberg·5h ago
Analysts lift ZYBT price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Bloomberg·1d ago
ZHENGYE BIOTECHNOLOGY-A announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.